Skip to main content
Premium Trial:

Request an Annual Quote

Promega, One Lambda to Co-market DNA Extraction, Testing Systems

NEW YORK (GenomeWeb News) – Promega and One Lambda have agreed to co-market Promega’s DNA extraction systems with One Lambda’s human leukocyte antigen tests, Promega said yesterday.
Under the agreement, the companies will market the Promega Maxwell 16 DNA extraction system along with One Lambda’s LABType SSO and Micro SSP tests to customers in the HLA market.
One Lambda VP of R&D Jar-How Lee said in a statement that Promega’s system “helps ensure consistent, reliable results” for One Lambda’s assays, and it helps eliminate problems with poor sample preparation. “Suboptimal sample extraction can lead to time-consuming rework and system failure, which slow results, decrease productivity and potentially compromise overall accuracy of the tests,” Lee added.
The Maxwell 16 System extracts DNA from blood, buffy coat, or buccal swabs in about 30 minutes to 40 minutes, and it reduces labor, reagents, and assay time, Promega said.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.